Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.81 |
| ▸ | CA6 | P23280 | 5/20 | 0.81 |
| ▸ | CA7 | P43166 | 5/20 | 0.81 |
| ▸ | CA9 | Q16790 | 5/20 | 0.81 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.81 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.81 |
| ▸ | CA2 | P00918 | 4/20 | 0.81 |
| ▸ | CA4 | P22748 | 4/20 | 0.81 |
| ▸ | CA5A | P35218 | 4/20 | 0.81 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.81 |
| ▸ | CA3 | P07451 | 3/20 | 0.81 |
| ▸ | F13A1 | P00488 | 2/20 | 0.81 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.81 |
| ▸ | THPO | P40225 | 2/20 | 0.81 |
| ▸ | CA1 | P00915 | 2/20 | 0.81 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.81 |
| ▸ | PKM | P14618 | 1/20 | 0.81 |
| ▸ | TSHR | P16473 | 1/20 | 0.81 |
| ▸ | MTOR | P42345 | 1/20 | 0.81 |
| ▸ | LMNA | P02545 | 3/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL817205 | 1.00 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL18700922 | 1.00 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL14030615 | 1.00 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL15306482 | 1.00 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL7206015 | 1.00 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL27516113 | 1.00 | CA12 (0.81) | CA12CA6CA7CA9CA14 | |
| SCHEMBL18496764 | 0.97 | CA12 (0.88) | CA12CA6CA7CA9CA14 | |
| Water SCHEMBL29135283 | 0.97 | CA12 (0.77) | CA12CA6CA7CA9CA14 | |
| Trientine SCHEMBL15016070 | 0.97 | CA12 (0.77) | CA12CA6CA7CA9CA14 | |
| SCHEMBL16281062 | 0.97 | CA12 (0.87) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170198232-A1 | LUBRICATION OIL ADDITIVE AND METHOD FOR MANUFACTURING SAME, AND LUBRICATION OIL COMPOSITION USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2017-07-13 | — | — | US | disclosed |
| EP-3162876-A1 | LUBRICATION OIL ADDITIVE AND METHOD FOR MANUFACTURING SAME, AND LUBRICATION OIL COMPOSITION USING SAME | Idemitsu Kosan Co., Ltd (JP) | 2017-05-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170198232-A1 | LUBRICATION OIL ADDITIVE AND METHOD FOR MANUFACTURING SAME, AND LUBRICATION OIL COMPOSITION USING SAME | NAP1L1, SYVN1, NR0B1 | CA12 2877/4885CA6 4709/4885CA7 4143/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.